Opioid Education and Naloxone Training
Expand your role as a kind and caring member of our community. The Student Health Center’s Opioid Education & Naloxone Training program is open to NYU students, employees, and faculty who want to increase their awareness of opioid usage and impact, and save lives by administering naloxone.
Why is this important?
Opioids are strong and potentially addictive prescription medications used short-term to manage severe pain. Opioids have serious risks of addiction and overdose. Too many opioids in your body can cause you to stop breathing– which could lead to death.
Naloxone (also known by its brand name, NARCAN) is a medicine that rapidly reverses an opioid overdose. Naloxone can quickly restore normal breathing to a person if their breathing has slowed or stopped because of an opioid overdose—but, naloxone has no effect on someone who does not have opioids in their system.
How can I get trained to administer naloxone?
You can learn to recognize an overdose and administer life-saving naloxone! Our Opioid Education & Naloxone Training will cover:
- Information about opioids
- Information about naloxone
- Risk factors for opioid misuse
- How to recognize an overdose
- How to respond to an overdose
- Good Samaritan laws and NYU campus policy
- How to get naloxone and refills
- Resources and referrals
Coming in Spring 2023: iLearn Module
To increase accessibility and allow all NYU students, faculty, and employees to be trained on their own timeline, the training will be offered asynchronously as an iLearn module beginning in Spring 2023.
More information about signing up for a training will be announced soon!
We Want Your Feedback
The SHC is committed to tailoring our educational content, including our opioid education and naloxone training, to meet the specific needs of the NYU community. We are gathering feedback from community members who participated in the virtual trainings this fall, which we are carefully reviewing, so we can address and integrate it into the iLearn module we will release in the spring.